An Adenovirus with Enhanced Infectivity Mediates Molecular Chemotherapy of Ovarian Cancer Cells and Allows Imaging of Gene Expression
Open Access
- 1 September 2001
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 4 (3) , 223-231
- https://doi.org/10.1006/mthe.2001.0446
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Update on adenovirus and its vectorsJournal of General Virology, 2000
- Thymidine Kinase Gene Therapy for Human Malignant Glioma, Using Replication-Deficient Retroviruses or AdenovirusesHuman Gene Therapy, 2000
- Adenoviral-Mediated Suicide Gene Therapy for Ovarian CancerMolecular Therapy, 2000
- A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancerNature Medicine, 2000
- Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancerCancer Gene Therapy, 2000
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vectorNature Genetics, 2000
- Adenovirus-Mediated p53 Gene Transfer in Sequence With Cisplatin to Tumors of Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- An Advanced Generation of Adenoviral Vectors Selectively Enhances Gene Transfer for Ovarian Cancer Gene Therapy ApproachesGynecologic Oncology, 1999
- Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJournal of Clinical Investigation, 1999